HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on hormones and fertility. Browse all Hormones & Fertility education

Your testosterone level is a number. What your body does with that number is a different question — and the answer sits not in your bloodwork but in your DNA. Specifically, in a polymorphic stretch of the AR gene called CAG repeats. The length of that sequence determines how efficiently your androgen receptor converts a testosterone signal into cellular action. Two men with identical serum testosterone can experience that testosterone very differently, and androgen receptor CAG repeat length is one of the primary genetic reasons why.

What Is the Androgen Receptor and What Do CAG Repeats Do?

The androgen receptor (AR) is the cellular protein that testosterone and DHT must bind to in order to exert their effects. Without a functional, responsive receptor, testosterone circulates in the blood but cannot signal. The AR gene contains a polymorphic CAG trinucleotide repeat sequence in exon 1 — a region where the codon "CAG" (coding for the amino acid glutamine) repeats a variable number of times. This repeat count is genetically determined, stable across a person's lifetime, and varies between individuals across a meaningful functional range.

The functional consequence is well-established: longer CAG repeat sequences reduce androgen receptor transactivation efficiency. Shorter repeat sequences increase it. In practical terms — shorter repeats mean a more responsive receptor that generates a stronger biological signal per unit of testosterone. Longer repeats mean a less efficient receptor that requires more testosterone to produce an equivalent signal downstream.

The PlexusDx Precision Peptide Genetic Test analyzes AR CAG repeats as part of 14 pathways, 49 peptides, and 150+ genetic insights — placing receptor sensitivity genetics within the full context of the Reproductive Health pathway, alongside the five other gene variants that complete the male androgen-estrogen picture.

How CAG Repeat Length Shapes Androgen Sensitivity

Longer CAG repeats are associated with reduced receptor transactivation: the receptor binds testosterone normally but generates a weaker downstream signal into gene expression. This has measurable biological consequences across the systems androgen receptor signaling governs — muscle protein synthesis, fat distribution, mood regulation, libido, bone density, and cognitive function all include androgen-receptor-mediated components.

A man with longer CAG repeats may experience symptoms consistent with relative androgen insufficiency even when his testosterone level is within the clinically normal range — because the receptor translating that level is operating below its theoretical maximum sensitivity. Conversely, a man with shorter repeats may be more responsive to lower testosterone levels than serum numbers alone would suggest.

This is why AR CAG repeat analysis adds a dimension to hormone assessment that blood panels cannot. Serum testosterone measures the signal. CAG repeat length measures how well the receptor reads it.

Why Testosterone Numbers Alone Don't Tell the Full Story

Consider two men at identical total testosterone levels. Man A carries shorter CAG repeats — his androgen receptor is highly efficient, generating a robust cellular response from that circulating testosterone. Man B carries longer repeats — his receptor is less efficient, producing a weaker downstream signal from the same hormonal substrate. Clinically, they look the same on paper. Biologically, they are not.

This has real implications for how androgen-pathway protocols are monitored and adjusted. A target testosterone level that produces strong androgen effects in Man A may be meaningfully insufficient for Man B — not because of protocol failure, but because receptor genetics set a different baseline. Providers who know a patient's AR CAG repeat status can factor in receptor-level sensitivity when interpreting bloodwork and setting pathway targets, rather than working from population averages that may not apply to that individual.

AR CAG Repeats and the Full Men's Hormone Gene Network

AR CAG repeats are one of 6 Reproductive Health insights the Precision Peptide Genetic Test analyzes as a connected system — part of the broader framework covered in the Complete Guide to Genetic Men's Hormone Testing:

CYP19A1 (aromatase) — controls how much testosterone is converted to estradiol before it reaches the androgen receptor. High aromatase activity reduces the androgen substrate available for receptor binding, interacting directly with receptor sensitivity to shape the net androgen effect. CYP19A1 and Estrogen Conversion in Men covers this pathway in detail.

SHBG — sex hormone binding globulin variants govern how much testosterone circulates free and bioavailable for receptor binding. SHBG supply and AR receptor sensitivity are two sides of the same functional equation. SHBG Genetics: Why Your Free Testosterone Varies explains how SHBG genetics shape this supply variable.

SRD5A2 — 5-alpha reductase converts testosterone to DHT, which binds the androgen receptor with approximately 2–3 times the affinity of testosterone itself. SRD5A2 variants affect the potency of the androgen signal presented to the receptor, making them directly relevant to how CAG repeat sensitivity is expressed in practice.

ESR1 and ESR2 — estrogen receptor variants determine tissue sensitivity to estradiol, the downstream product of aromatization. In men, some androgen pathway effects — particularly in bone and cognitive function — are partially mediated through estrogen receptors. The AR-ESR interplay is part of the full hormonal picture no single gene insight can capture alone.

Taken together, these 6 insights map the genetic architecture of male androgen signaling from signal availability through receptor sensitivity to downstream response. AR CAG repeats are the receptor dimension of that map — the piece that tells you how efficiently the signal is read, not just how much signal exists.

What Your AR CAG Results Can and Cannot Tell You

AR CAG repeat analysis reveals your genetic receptor sensitivity baseline — the efficiency your androgen receptor brings to each unit of testosterone in circulation. It does not tell you what your testosterone level should be. It does not diagnose any clinical condition. And it does not predict your response to any specific androgen-pathway compound or protocol category.

What it delivers is precision context: where your receptor sits on the sensitivity continuum, which informs how your provider reads your bloodwork, sets pathway targets, and monitors your response over time. Genetics as a guide, not a guarantee — your AR variant is one well-defined input in a multi-variable clinical picture. The Precision Peptide Genetic Test delivers that input with specificity across 6 Reproductive Health insights, 14 total pathways, and 150+ genetic insights built for exactly this kind of precision approach.

The Precision Peptide Genetic Test analyzes how your genes influence hormone-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to understand your androgen receptor genetics and where your AR CAG repeat length fits in your hormone profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions About Androgen Receptor CAG Repeats

What are androgen receptor CAG repeats and why do they matter?

Androgen receptor CAG repeats are a polymorphic DNA sequence in the AR gene whose length determines receptor transactivation efficiency. Shorter repeats mean higher androgen sensitivity; longer repeats mean lower sensitivity. The Precision Peptide Genetic Test analyzes AR CAG repeats as one of 6 Reproductive Health insights within 14 pathways and 150+ genetic insights.

Can two men with the same testosterone level have different androgen effects?

Yes — and AR CAG repeat length is a primary reason. A man with shorter repeats has a more sensitive receptor and generates a stronger cellular response at the same testosterone level. A man with longer repeats may experience relative androgen insufficiency even within the normal range. Serum levels alone don't capture receptor-level sensitivity.

How does AR CAG repeat length interact with other men's hormone genes?

AR CAG repeats work alongside CYP19A1 (aromatase conversion), SHBG (free testosterone availability), SRD5A2 (DHT production via 5-alpha reductase), and ESR1/ESR2 (estrogen receptor sensitivity). The Precision Peptide Genetic Test analyzes all 6 Reproductive Health insights together — giving providers a complete picture of androgen signaling, not a single serum data point.

This article is part of the PlexusDx Education Hub. Browse all Hormones & Fertility education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.